HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P S Gaynon Selected Research

Therapeutics

6/2001Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P S Gaynon Research Topics

Disease

4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2014 - 08/2000
1Philadelphia Chromosome
07/2014
1monosomy Chromosome 7
05/2004
1Neoplasms (Cancer)
05/2004

Drug/Important Bio-Agent (IBA)

1Imatinib Mesylate (Gleevec)FDA Link
07/2014
1factor AIBA
05/2004

Therapy/Procedure

2Drug Therapy (Chemotherapy)
07/2014 - 08/2000
1Therapeutics
06/2001
1Induction Chemotherapy
08/2000